GRL-0496 is a potent small molecule inhibitor of SARS-CoV 3CLpro, demonstrating an IC50 of 30 nM in enzymatic assays and antiviral activity with an EC50 of 6.9 µM in cellular models. It serves as a valuable research tool for studying coronavirus replication and the development of protease-targeted therapeutics in both in vitro and in vivo contexts.